Wall Street's Most Wanted: 2 Highly Shorted Stocks Right Now

Group 1: Short Selling Overview - Short selling is a controversial yet essential aspect of the stock market, allowing bearish investors to profit from declining stock prices [1] - Short interest as a percentage of shares outstanding indicates bearish sentiment, with a higher percentage reflecting greater bets on stock price declines [2] Group 2: NuScale Power - NuScale Power has a significant short interest percentage of 21% and has seen a remarkable stock return of 610% over the past 52 weeks, despite only generating $7 million in revenue [3][4] - The company specializes in small modular reactors (SMRs), which are considered a potentially cheaper and faster alternative to traditional large nuclear reactors [5] - NuScale is the first and only company to receive SMR design certification from the U.S. Nuclear Regulatory Commission (NRC) and aims to gain approval for another design by mid-2025 [6][7] Group 3: Hims & Hers Health - Hims & Hers Health has nearly 27% of its shares sold short, benefiting from a drug-compounding strategy in the weight loss market amid high consumer demand [8] - The company experienced a 69% revenue increase in 2024 due to selling compounded semaglutide, but faced a significant drop in share price after the FDA removed semaglutide from its shortage list [10] - Hims argues it can still sell personalized formulations of semaglutide, although this may attract legal scrutiny [11]